This report was recently updated on November 15 2024 with the latest and most recent
market numbers
Global RSV Diagnostic Products Market Size, Trends & Analysis - Forecasts to 2028 By Product Type (Kits and Assays, Instruments, and Others), By Method (Molecular Diagnostics, Rapid Antigen Detection Test, and Others), By End User (Hospitals and Clinics, Clinical Laboratories, and Others), and By Region (North America, Asia Pacific, Central and South America, Europe, and Middle East and Africa), Competitive Landscape, Company Market Share Analysis, and End User Analysis
The global RSV diagnostic products market is expected to exhibit a CAGR of 11.4% from 2023 to 2028. RSV (respiratory syncytial virus) diagnostic products encompass various tests like molecular assays, antigen detection, serological tests, and viral cultures used to identify respiratory syncytial virus in patients. These tests, ranging from highly sensitive molecular methods like PCR to rapid antigen detection at point-of-care, aid healthcare professionals in promptly diagnosing RSV infections. Each test differs in sensitivity, turnaround time, and suitability for different clinical scenarios, aiming to improve accuracy and accessibility in managing RSV, particularly in vulnerable populations. Ongoing research aims to enhance these diagnostics for better infection management.
Many factors drive the growth of the global RSV diagnostic products market. A significant factor is the increasing incidence of respiratory syncytial virus infections, particularly among vulnerable groups like infants and the aged. Diagnostic advances, including PCR and quick point-of-care testing, are critical in identifying RSV because they enhance accuracy and speed. Heightened awareness among healthcare professionals and patients about early detection and treatment, supported by government initiatives and funding, further fuels the demand for these diagnostics. Additionally, the rising healthcare expenditure globally and the susceptibility of high-risk populations contribute to the market's growth by encouraging the development and adoption of advanced RSV diagnostic tools.
Despite the promising growth prospects, the global RSV diagnostic products market faces certain restraints that hinder its growth. Advancements in RSV vaccines represent a potential restraint in the RSV diagnostic products market. As vaccine research and development progress, successful vaccine formulations could potentially reduce RSV infection's overall prevalence and severity. A highly effective vaccine that prevents RSV infection could decrease demand for diagnostic products, particularly in the long term, as fewer individuals would contract the virus. However, while vaccines may mitigate the spread of RSV, the need for diagnostics could persist for surveillance, monitoring vaccine efficacy, and diagnosing breakthrough infections in vaccinated populations. However, the demand might see a reduction compared to pre-vaccine scenarios. The market might need to adapt by focusing on specialized diagnostics or diversifying into other respiratory pathogens to compensate for potential declines in RSV diagnostic demand due to successful vaccination efforts.
Based on the end user, the market is segmented into hospitals and clinics, clinical laboratories, and others. The clinical laboratories segment is expected to be the largest segment during the forecast period. Clinical labs are centralized facilities equipped with advanced molecular and antigen detection technologies. They handle a high volume of diagnostic tests, providing accurate and reliable results crucial for patient management. These labs are well-equipped to perform sophisticated tests, including PCR assays, viral cultures, and serological tests, meeting the demands for comprehensive RSV diagnostics, especially in complex cases and for population-scale screenings.
The hospitals and clinics segments are expected to be the fastest-growing segments in the global RSV diagnostic products market during the forecast period. These settings are primary points for diagnosing respiratory infections, and RSV diagnostics are crucial for prompt treatment. The high patient influx in hospitals and clinics demands rapid, accurate testing to identify RSV cases swiftly, enabling timely interventions. Moreover, technological advancements and increased awareness in these healthcare facilities further drive the adoption of advanced RSV diagnostic tools, fueling the segment's rapid growth.
On the basis of product type, the market is segmented into kits and assays, instruments, and others. The kits and assays segment are expected to be the largest and fastest growing segment during the forecast period. These kits offer convenience, rapid results, and high accuracy in detecting respiratory syncytial virus (RSV). The increasing preference for point-of-care testing and the development of innovative, user-friendly assay kits, including molecular tests like PCR assays, has driven their popularity. Their ease of use in various healthcare settings, coupled with advancements ensuring greater sensitivity and specificity, contributes significantly to their rapid growth within the market.
Based on method, the market is segmented into molecular diagnostics, rapid antigen detection test, and others. The rapid antigen detection test segment is expected to be the largest segment during the forecast period. These tests offer simplicity in administration and deliver rapid outcomes, making them widely adopted in various healthcare settings. Additionally, their cost-effectiveness and ease of use contribute to their popularity, especially in resource-limited settings. The ability to swiftly confirm RSV infections aids in prompt patient management, leading to widespread utilization and dominance in the market.
The molecular diagnostics segment is expected to be the fastest-growing segment in the global RSV diagnostic products market during the forecast period. Techniques like PCR offer rapid and accurate identification of RSV genetic material from respiratory samples. Their ability to swiftly deliver precise results, crucial in managing infections, has led to widespread adoption. Moreover, ongoing advancements in molecular technologies continually enhance test performance, making these diagnostics the preferred choice for quick, reliable RSV detection, driving their rapid market growth.
North America is analysed to account for the largest share in the global RSV diagnostic products market during the forecast period. The region exhibits advanced healthcare infrastructure and a robust research landscape, fostering the development and adoption of cutting-edge diagnostic technologies like molecular diagnostics and chromatographic immunoassays. Strategic partnerships between pharmaceutical giants and diagnostic manufacturers have been more prevalent in this region, paving the way for innovative companion diagnostics. Additionally, a higher healthcare expenditure, coupled with a strong emphasis on automated healthcare testing for accurate and rapid disease diagnosis, further consolidates North America's position as the largest market for RSV diagnostic products..
Asia Pacific is expected to be the fastest-growing region across the global RSV diagnostic products market. Countries like China, India, Japan, and Malaysia exhibit robust growth due to developing healthcare systems and extensive government initiatives. The rising infant population, particularly in India with nearly one-fifth of global annual childbirths, significantly drives market expansion. Increasing healthcare spending in nations like India, Bangladesh, and Malaysia, coupled with substantial government support, fuels market growth. Moreover, the region boasts untapped opportunities, continual improvements in healthcare infrastructure, economic development, and heightened patient awareness levels, all contributing to the accelerated pace of market growth in APAC for RSV diagnostic products.
Key players operating in the global RSV diagnostic products market include Biomerieux, BD, F. Hoffman La. Roche Ltd., Danaher, Thermo Fisher Scientific Inc., Luminex Corp, BioCartis, Hologic, Inc., Beckman Coulter Inc., and Bio-Rad Laboratories Inc., among others.
Please note: This is not an exhaustive list of companies profiled in the report.
In May 2023, Domus Diagnostics, a U.S.-based diagnostics company, was awarded a USD 2.4 Million grant by the National Institutes of Health to develop a nucleic acid amplification and detection test for COVID-19, Flu-A, Flu-B, and RSV. The grant will support the validation and scaling of Domus's testing platform for clinical trial readiness, enabling user-friendly, accurate, and effective infectious disease testing at home, doctors' offices, or community facilities.
In February 2023, Anavasi Diagnostics, a medical technology company funded by NIH/RADx, received an Emergency Use Authorization from the U.S. FDA for its AscencioDx COVID-19 Test and AscencioDx Molecular Detector.
1 STRATEGIC INSIGHTS ON NEW REVENUE POCKETS
1.1 Strategic Opportunity & Attractiveness Analysis
1.1.1 Hot Revenue Pockets
1.1.2 Market Attractiveness Score
1.1.3 Revenue Impacting Opportunity
1.1.4 High Growing Region/Country
1.1.5 Competitor Analysis
1.1.6 Consumer Analysis
1.2 Global Market Estimates' View
1.3 Strategic Insights across Business Functions
1.3.1 For Chief Executive Officers
1.3.2 For Chief Marketing Officers
1.3.3 For Chief Strategy Officers
1.4 Evaluate the Potential of your Existing Business Lines vs. New Lines to Enter Into
2 TECHNOLOGICAL TRENDS
2.1 Technological Adoption Rate
2.2 Current Trend Impact Analysis
2.3 Future Trend Impact Analysis
3.1 Market Pyramid Analysis
3.1.1 Introduction
3.1.2 Adjacent Market Opportunities
3.1.3 Ancillary Market Opportunities
3.2 Demand Side Analysis
3.2.1 Market Drivers: Impact Analysis
3.2.2 Market Restraints: Impact Analysis
3.2.3 Market Opportunities: Impact Analysis
3.2.4 Market Challenges: Impact Analysis
3.3 Supply Side Analysis
3.3.1 Porter’s Five Forces Analysis
3.3.1.1 Threat of New Entrants
3.3.1.2 Threat of New Substitutes
3.3.1.3 Bargaining Power of Suppliers
3.3.1.4 Bargaining Power of Buyers
3.3.1.5 Intensity of Competitive Rivalry
3.3.2 SWOT Analysis; By Factor (Political & Legal, Economic, and Technological)
3.3.2.1 Political Landscape
3.3.2.2 Economic Landscape
3.3.2.3 Social Landscape
3.3.2.4 Technology Landscape
3.3.3 Value Chain Analysis
3.3.4 Trend Analysis
3.3.5 Gap Analysis
3.3.6 Cost Analysis
4 GLOBAL RSV DIAGNOSTIC PRODUCTS MARKET, BY METHOD
4.1 Introduction
4.2 RSV Diagnostic Products Market: Method Scope Key Takeaways
4.3 Revenue Growth Analysis, 2022 & 2028
4.4 Molecular Diagnostics
4.4.1 Molecular Diagnostics Market Estimates and Forecast, 2020-2028 (USD Billion)
4.5 Rapid Antigen Detection Test
4.5.1 Rapid Antigen Detection Test Market Estimates and Forecast, 2020-2028 (USD Billion)
4.6 Other Methods
4.6.1 Other Methods Market Estimates and Forecast, 2020-2028 (USD Billion)
5 GLOBAL RSV DIAGNOSTIC PRODUCTS MARKET, BY PRODUCT TYPE
5.1 Introduction
5.2 RSV Diagnostic Products Market: Product Type Scope Key Takeaways
5.3 Revenue Growth Analysis, 2022 & 2028
5.4 Kits and Assays
5.4.1 Kits and Assays Market Estimates and Forecast, 2020-2028 (USD Billion)
5.5 Instruments
5.5.1 Instruments Market Estimates and Forecast, 2020-2028 (USD Billion)
5.6 Other Products
5.6.1 Other Products Market Estimates and Forecast, 2020-2028 (USD Billion)
6 GLOBAL RSV DIAGNOSTIC PRODUCTS MARKET, BY END USER
6.1 Introduction
6.2 RSV Diagnostic Products Market: End User Scope Key Takeaways
6.3 Revenue Growth Analysis, 2022 & 2028
6.4 Hospitals & Clinics
6.4.1 Hospitals & Clinics Market Estimates and Forecast, 2020-2028 (USD Billion)
6.5 Clinical Laboratories
6.5.1 Clinical Laboratories Market Estimates and Forecast, 2020-2028 (USD Billion)
6.6 Other End Users
6.6.1 Other End Users Market Estimates and Forecast, 2020-2028 (USD Billion)
7 GLOBAL RSV DIAGNOSTIC PRODUCTS MARKET, BY REGION
7.1 Introduction
7.2 North America RSV Diagnostic Products Market Estimates and Forecast, 2020-2028 (USD Billion)
7.2.1 By Method
7.2.2 By Product Type
7.2.3 By End User
7.2.4 By Country
7.2.4.1 U.S. RSV Diagnostic Products Market Estimates and Forecast, 2020-2028 (USD Billion)
7.2.4.1.1 By Method
7.2.4.1.2 By Product Type
7.2.4.1.3 By End User
7.2.4.2 Canada RSV Diagnostic Products Market Estimates and Forecast, 2020-2028 (USD Billion)
7.2.4.2.1 By Method
7.2.4.2.2 By Product Type
7.2.4.2.3 By End User
7.2.4.3 Mexico RSV Diagnostic Products Market Estimates and Forecast, 2020-2028 (USD Billion)
7.2.4.3.1 By Method
7.2.4.3.2 By Product Type
7.2.4.3.3 By End User
7.3 Europe RSV Diagnostic Products Market Estimates and Forecast, 2020-2028 (USD Billion)
7.3.1 By Method
7.3.2 By Product Type
7.3.3 By End User
7.3.4 By Country
7.3.4.1 Germany RSV Diagnostic Products Market Estimates and Forecast, 2020-2028 (USD Billion)
7.3.4.1.1 By Method
7.3.4.1.2 By Product Type
7.3.4.1.3 By End User
7.3.4.2 U.K. RSV Diagnostic Products Market Estimates and Forecast, 2020-2028 (USD Billion)
7.3.4.2.1 By Method
7.3.4.2.2 By Product Type
7.3.4.2.3 By End User
7.3.4.3 France RSV Diagnostic Products Market Estimates and Forecast, 2020-2028 (USD Billion)
7.3.4.3.1 By Method
7.3.4.3.2 By Product Type
7.3.4.3.3 By End User
7.3.4.4 Italy RSV Diagnostic Products Market Estimates and Forecast, 2020-2028 (USD Billion)
7.3.4.4.1 By Method
7.3.4.4.2 By Product Type
7.2.4.4.3 By End User
7.3.4.5 Spain RSV Diagnostic Products Market Estimates and Forecast, 2020-2028 (USD Billion)
7.3.4.5.1 By Method
7.3.4.5.2 By Product Type
7.2.4.5.3 By End User
7.3.4.6 Netherlands RSV Diagnostic Products Market Estimates and Forecast, 2020-2028 (USD Billion)
7.3.4.7.1 By Method
7.3.4.7.2 By Product Type
7.2.4.7.3 By End User
7.3.4.7 Rest of Europe RSV Diagnostic Products Market Estimates and Forecast, 2020-2028 (USD Billion)
7.3.4.7.1 By Method
7.3.4.7.2 By Product Type
7.2.4.7.3 By End User
7.4 Asia Pacific RSV Diagnostic Products Market Estimates and Forecast, 2020-2028 (USD Billion)
7.4.1 By Method
7.4.2 By Product Type
7.4.3 By End User
7.4.4 By Country
7.4.4.1 China RSV Diagnostic Products Market Estimates and Forecast, 2020-2028 (USD Billion)
7.4.4.1.1 By Method
7.4.4.1.2 By Product Type
7.4.4.1.3 By End User
7.4.4.2 Japan RSV Diagnostic Products Market Estimates and Forecast, 2020-2028 (USD Billion)
7.4.4.2.1 By Method
7.4.4.2.2 By Product Type
7.4.4.2.3 By End User
7.4.4.3 India RSV Diagnostic Products Market Estimates and Forecast, 2020-2028 (USD Billion)
7.4.4.3.1 By Method
7.4.4.3.2 By Product Type
7.4.4.3.3 By End User
7.4.4.4 South Korea RSV Diagnostic Products Market Estimates and Forecast, 2020-2028 (USD Billion)
7.4.4.4.1 By Method
7.4.4.4.2 By Product Type
7.4.4.4.3 By End User
7.4.4.5 Singapore RSV Diagnostic Products Market Estimates and Forecast, 2020-2028 (USD Billion)
7.4.4.5.1 By Method
7.4.4.5.2 By Product Type
7.4.4.5.3 By End User
7.4.4.6 Malaysia RSV Diagnostic Products Market Estimates and Forecast, 2020-2028 (USD Billion)
7.4.4.7.1 By Method
7.4.4.7.2 By Product Type
7.4.4.7.3 By End User
7.4.4.7 Thailand RSV Diagnostic Products Market Estimates and Forecast, 2020-2028 (USD Billion)
7.4.4.7.1 By Method
7.4.4.7.2 By Product Type
7.4.4.7.3 By End User
7.4.4.8 Indonesia RSV Diagnostic Products Market Estimates and Forecast, 2020-2028 (USD Billion)
7.4.4.8.1 By Method
7.4.4.8.2 By Product Type
7.4.4.8.3 By End User
7.4.4.9 Vietnam RSV Diagnostic Products Market Estimates and Forecast, 2020-2028 (USD Billion)
7.4.4.9.1 By Method
7.4.4.9.2 By Product Type
7.4.4.9.3 By End User
7.4.4.10 Taiwan RSV Diagnostic Products Market Estimates and Forecast, 2020-2028 (USD Billion)
7.4.4.10.1 By Method
7.4.4.10.2 By Product Type
7.4.4.10.3 By End User
7.4.4.11 Rest of Asia Pacific RSV Diagnostic Products Market Estimates and Forecast, 2020-2028 (USD Billion)
7.4.4.11.1 By Method
7.4.4.11.2 By Product Type
7.4.4.11.3 By End User
7.5 Middle East and Africa RSV Diagnostic Products Market Estimates and Forecast, 2020-2028 (USD Billion)
7.5.1 By Method
7.5.2 By Product Type
7.5.3 By End User
7.5.4 By Country
7.5.4.1 Saudi Arabia RSV Diagnostic Products Market Estimates and Forecast, 2020-2028 (USD Billion)
7.5.4.1.1 By Method
7.5.4.1.2 By Product Type
7.5.4.1.3 By End User
7.5.4.2 U.A.E. RSV Diagnostic Products Market Estimates and Forecast, 2020-2028 (USD Billion)
7.5.4.2.1 By Method
7.5.4.2.2 By Product Type
7.5.4.2.3 By End User
7.5.4.3 Israel RSV Diagnostic Products Market Estimates and Forecast, 2020-2028 (USD Billion)
7.5.4.3.1 By Method
7.5.4.3.2 By Product Type
7.5.4.3.3 By End User
7.5.4.4 South Africa RSV Diagnostic Products Market Estimates and Forecast, 2020-2028 (USD Billion)
7.5.4.4.1 By Method
7.5.4.4.2 By Product Type
7.5.4.4.3 By End User
7.5.4.5 Rest of Middle East and Africa RSV Diagnostic Products Market Estimates and Forecast, 2020-2028 (USD Billion)
7.5.4.5.1 By Method
7.5.4.5.2 By Product Type
7.5.4.5.2 By End User
7.6 Central and South America RSV Diagnostic Products Market Estimates and Forecast, 2020-2028 (USD Billion)
7.7.1 By Method
7.7.2 By Product Type
7.7.3 By End User
7.7.4 By Country
7.7.4.1 Brazil RSV Diagnostic Products Market Estimates and Forecast, 2020-2028 (USD Billion)
7.7.4.1.1 By Method
7.7.4.1.2 By Product Type
7.7.4.1.3 By End User
7.7.4.2 Argentina RSV Diagnostic Products Market Estimates and Forecast, 2020-2028 (USD Billion)
7.7.4.2.1 By Method
7.7.4.2.2 By Product Type
7.7.4.2.3 By End User
7.7.4.3 Chile RSV Diagnostic Products Market Estimates and Forecast, 2020-2028 (USD Billion)
7.7.4.3.1 By Method
7.7.4.3.2 By Product Type
7.7.4.3.3 By End User
7.7.4.4 Rest of Central and South America RSV Diagnostic Products Market Estimates and Forecast, 2020-2028 (USD Billion)
7.7.4.4.1 By Method
7.7.4.4.2 By Product Type
7.7.4.4.3 By End User
8 COMPETITIVE LANDCAPE
8.1 Company Market Share Analysis
8.2 Four Quadrant Positioning Matrix
8.2.1 Market Leaders
8.2.2 Market Visionaries
8.2.3 Market Challengers
8.2.4 Niche Market Players
8.3 Vendor Landscape
8.3.1 North America
8.3.2 Europe
8.3.3 Asia Pacific
8.3.4 Rest of the World
8.4 Company Profiles
8.4.1 BioMeriux
8.4.1.1 Business Description & Financial Analysis
8.4.1.2 SWOT Analysis
8.4.1.3 Products & Services Offered
8.4.1.4 Strategic Alliances between Business Partners
8.4.2 BD
8.4.2.1 Business Description & Financial Analysis
8.4.2.2 SWOT Analysis
8.4.2.3 Products & Services Offered
8.4.2.4 Strategic Alliances between Business Partners
8.4.3 F. Hoffman La. Roche Ltd.
8.4.3.1 Business Description & Financial Analysis
8.4.3.2 SWOT Analysis
8.4.3.3 Products & Services Offered
8.4.3.4 Strategic Alliances between Business Partners
8.4.4 Danaher
8.4.4.1 Business Description & Financial Analysis
8.4.4.2 SWOT Analysis
8.4.4.3 Products & Services Offered
8.4.4.4 Strategic Alliances between Business Partners
8.4.5 Thermo Fisher Scientific Inc.
8.4.5.1 Business Description & Financial Analysis
8.4.5.2 SWOT Analysis
8.4.5.3 Products & Services Offered
8.4.5.4 Strategic Alliances between Business Partners
8.4.6 Luminex Corp.
8.4.7.1 Business Description & Financial Analysis
8.4.7.2 SWOT Analysis
8.4.7.3 Products & Services Offered
8.4.7.4 Strategic Alliances between Business Partners
8.4.7 BioCartis
8.4.7.1 Business Description & Financial Analysis
8.4.7.2 SWOT Analysis
8.4.7.3 Products & Services Offered
8.4.8.4 Strategic Alliances between Business Partners
8.4.8 Hologic Inc.
8.4.8.1 Business Description & Financial Analysis
8.4.8.2 SWOT Analysis
8.4.8.3 Products & Services Offered
8.4.8.4 Strategic Alliances between Business Partners
8.4.9 Beckman Coulter Inc.
8.4.9.1 Business Description & Financial Analysis
8.4.9.2 SWOT Analysis
8.4.9.3 Products & Services Offered
8.4.9.4 Strategic Alliances between Business Partners
8.4.10 Bio-Rad Laboratories Inc.
8.4.10.1 Business Description & Financial Analysis
8.4.10.2 SWOT Analysis
8.4.10.3 Products & Services Offered
8.4.10.4 Strategic Alliances between Business Partners
8.4.11 Other Companies
8.4.11.1 Business Description & Financial Analysis
8.4.11.2 SWOT Analysis
8.4.11.3 Products & Services Offered
8.4.11.4 Strategic Alliances between Business Partners
9 RESEARCH METHODOLOGY
9.1 Market Introduction
9.1.1 Market Definition
9.1.2 Market Scope & Segmentation
9.2 Information Procurement
9.2.1 Secondary Research
9.2.1.1 Purchased Databases
9.2.1.2 GMEs Internal Data Repository
9.2.1.3 Secondary Resources & Third Party Perspectives
9.2.1.4 Company Information Sources
9.2.2 Primary Research
9.2.2.1 Various Types of Respondents for Primary Interviews
9.2.2.2 Number of Interviews Conducted throughout the Research Process
9.2.2.3 Primary Stakeholders
9.2.2.4 Discussion Guide for Primary Participants
9.2.3 Expert Panels
9.2.3.1 Expert Panels Across 30+ Industry
9.2.4 Paid Local Experts
9.2.4.1 Paid Local Experts Across 30+ Industry Across each Region
9.3 Market Estimation
9.3.1 Top-Down Approach
9.3.1.1 Macro-Economic Indicators Considered
9.3.1.2 Micro-Economic Indicators Considered
9.3.2 Bottom Up Approach
9.3.2.1 Company Share Analysis Approach
9.3.2.2 Estimation of Potential Product Sales
9.4 Data Triangulation
9.4.1 Data Collection
9.4.2 Time Series, Cross Sectional & Panel Data Analysis
9.4.3 Cluster Analysis
9.5 Analysis and Output
9.5.1 Inhouse AI Based Real Time Analytics Tool
9.5.2 Output From Desk & Primary Research
9.6 Research Assumptions & Limitations
9.7.1 Research Assumptions
9.7.2 Research Limitations
LIST OF TABLES
1 Global RSV Diagnostic Products Market, By Method, 2020-2028 (USD Billion)
2 Molecular Diagnostics Market, By Region, 2020-2028 (USD Billion)
3 Rapid Antigen Detection Test Market, By Region, 2020-2028 (USD Billion)
4 Other Methods Market, By Region, 2020-2028 (USD Billion)
5 Global RSV Diagnostic Products Market, By Product Type, 2020-2028 (USD Billion)
6 Kits and Assays Market, By Region, 2020-2028 (USD Billion)
7 Instruments Market, By Region, 2020-2028 (USD Billion)
8 Other Products Market, By Region, 2020-2028 (USD Billion)
9 Global RSV Diagnostic Products Market, By End User, 2020-2028 (USD Billion)
10 Hospitals & Clinics Market, By Region, 2020-2028 (USD Billion)
11 Clinical Laboratories Market, By Region, 2020-2028 (USD Billion)
12 Other End Users Market, By Region, 2020-2028 (USD Billion)
13 Regional Analysis, 2020-2028 (USD Billion)
14 North America RSV Diagnostic Products Market, By Method, 2020-2028 (USD Billion)
15 North America RSV Diagnostic Products Market, By Product Type, 2020-2028 (USD Billion)
16 North America RSV Diagnostic Products Market, By End User, 2020-2028 (USD Billion)
17 North America RSV Diagnostic Products Market, By Country, 2020-2028 (USD Billion)
18 U.S. RSV Diagnostic Products Market, By Method, 2020-2028 (USD Billion)
19 U.S. RSV Diagnostic Products Market, By Product Type, 2020-2028 (USD Billion)
20 U.S. RSV Diagnostic Products Market, By End User, 2020-2028 (USD Billion)
21 Canada RSV Diagnostic Products Market, By Method, 2020-2028 (USD Billion)
22 Canada RSV Diagnostic Products Market, By Product Type, 2020-2028 (USD Billion)
23 Canada RSV Diagnostic Products Market, By End User, 2020-2028 (USD Billion)
24 Mexico RSV Diagnostic Products Market, By Method, 2020-2028 (USD Billion)
25 Mexico RSV Diagnostic Products Market, By Product Type, 2020-2028 (USD Billion)
26 Mexico RSV Diagnostic Products Market, By End User, 2020-2028 (USD Billion)
27 Europe RSV Diagnostic Products Market, By Method, 2020-2028 (USD Billion)
28 Europe RSV Diagnostic Products Market, By Product Type, 2020-2028 (USD Billion)
29 Europe RSV Diagnostic Products Market, By End User, 2020-2028 (USD Billion)
30 EUROPE RSV Diagnostic Products Market, By Country, 2020-2028 (USD Billion)
31 Germany RSV Diagnostic Products Market, By Method, 2020-2028 (USD Billion)
32 Germany RSV Diagnostic Products Market, By Product Type, 2020-2028 (USD Billion)
33 Germany RSV Diagnostic Products Market, By End User, 2020-2028 (USD Billion)
34 U.K. RSV Diagnostic Products Market, By Method, 2020-2028 (USD Billion)
35 U.K. RSV Diagnostic Products Market, By Product Type, 2020-2028 (USD Billion)
36 U.K. RSV Diagnostic Products Market, By End User, 2020-2028 (USD Billion)
37 France RSV Diagnostic Products Market, By Method, 2020-2028 (USD Billion)
38 France RSV Diagnostic Products Market, By Product Type, 2020-2028 (USD Billion)
39 France RSV Diagnostic Products Market, By End User, 2020-2028 (USD Billion)
40 Italy RSV Diagnostic Products Market, By Method, 2020-2028 (USD Billion)
41 Italy RSV Diagnostic Products Market, By Product Type Type, 2020-2028 (USD Billion)
42 Italy RSV Diagnostic Products Market, By End User, 2020-2028 (USD Billion)
43 Spain RSV Diagnostic Products Market, By Method, 2020-2028 (USD Billion)
44 Spain RSV Diagnostic Products Market, By Product Type, 2020-2028 (USD Billion)
45 Spain RSV Diagnostic Products Market, By End User, 2020-2028 (USD Billion)
46 Netherland RSV Diagnostic Products Market, By Method, 2020-2028 (USD Billion)
47 Netherland RSV Diagnostic Products Market, By Product Type, 2020-2028 (USD Billion)
48 Netherland RSV Diagnostic Products Market, By End User, 2020-2028 (USD Billion)
49 Rest Of Europe RSV Diagnostic Products Market, By Method, 2020-2028 (USD Billion)
50 Rest Of Europe RSV Diagnostic Products Market, By Product Type, 2020-2028 (USD Billion)
51 Rest of Europe RSV Diagnostic Products Market, By End User, 2020-2028 (USD Billion)
52 Asia Pacific RSV Diagnostic Products Market, By Method, 2020-2028 (USD Billion)
53 Asia Pacific RSV Diagnostic Products Market, By Product Type, 2020-2028 (USD Billion)
54 Asia Pacific RSV Diagnostic Products Market, By End User, 2020-2028 (USD Billion)
55 Asia Pacific RSV Diagnostic Products Market, By Country, 2020-2028 (USD Billion)
56 China RSV Diagnostic Products Market, By Method, 2020-2028 (USD Billion)
57 China RSV Diagnostic Products Market, By Product Type, 2020-2028 (USD Billion)
58 China RSV Diagnostic Products Market, By End User, 2020-2028 (USD Billion)
59 India RSV Diagnostic Products Market, By Method, 2020-2028 (USD Billion)
60 India RSV Diagnostic Products Market, By Product Type, 2020-2028 (USD Billion)
61 India RSV Diagnostic Products Market, By End User, 2020-2028 (USD Billion)
62 Japan RSV Diagnostic Products Market, By Method, 2020-2028 (USD Billion)
63 Japan RSV Diagnostic Products Market, By Product Type, 2020-2028 (USD Billion)
64 Japan RSV Diagnostic Products Market, By End User, 2020-2028 (USD Billion)
65 South Korea RSV Diagnostic Products Market, By Method, 2020-2028 (USD Billion)
66 South Korea RSV Diagnostic Products Market, By Product Type, 2020-2028 (USD Billion)
67 South Korea RSV Diagnostic Products Market, By End User, 2020-2028 (USD Billion)
68 Australia RSV Diagnostic Products Market, By Method, 2020-2028 (USD Billion)
69 Australia RSV Diagnostic Products Market, By Product Type, 2020-2028 (USD Billion)
70 Australia RSV Diagnostic Products Market, By End User, 2020-2028 (USD Billion)
71 Thailand RSV Diagnostic Products Market, By Method, 2020-2028 (USD Billion)
72 Thailand RSV Diagnostic Products Market, By Product Type, 2020-2028 (USD Billion)
73 Thailand RSV Diagnostic Products Market, By End User, 2020-2028 (USD Billion)
74 Vietnam RSV Diagnostic Products Market, By Method, 2020-2028 (USD Billion)
75 Vietnam RSV Diagnostic Products Market, By Product Type, 2020-2028 (USD Billion)
76 Vietnam RSV Diagnostic Products Market, By End User, 2020-2028 (USD Billion)
77 indonesia RSV Diagnostic Products Market, By Method, 2020-2028 (USD Billion)
78 indonesia RSV Diagnostic Products Market, By Product Type, 2020-2028 (USD Billion)
79 indonesia RSV Diagnostic Products Market, By End User, 2020-2028 (USD Billion)
80 Malaysia RSV Diagnostic Products Market, By Method, 2020-2028 (USD Billion)
81 Malaysia RSV Diagnostic Products Market, By Product Type, 2020-2028 (USD Billion)
82 Malaysia RSV Diagnostic Products Market, By End User, 2020-2028 (USD Billion)
83 Philippines RSV Diagnostic Products Market, By Method, 2020-2028 (USD Billion)
84 Philippines RSV Diagnostic Products Market, By Product Type, 2020-2028 (USD Billion)
85 Philippines RSV Diagnostic Products Market, By End User, 2020-2028 (USD Billion)
86 Singapore RSV Diagnostic Products Market, By Method, 2020-2028 (USD Billion)
87 Singapore RSV Diagnostic Products Market, By Product Type, 2020-2028 (USD Billion)
88 Singapore RSV Diagnostic Products Market, By End User, 2020-2028 (USD Billion)
89 Rest of APAC RSV Diagnostic Products Market, By Method, 2020-2028 (USD Billion)
90 Rest of APAC RSV Diagnostic Products Market, By Product Type, 2020-2028 (USD Billion)
91 Rest of APAC RSV Diagnostic Products Market, By End User, 2020-2028 (USD Billion)
92 Middle East and Africa RSV Diagnostic Products Market, By Method, 2020-2028 (USD Billion)
93 Middle East and Africa RSV Diagnostic Products Market, By Product Type, 2020-2028 (USD Billion)
94 Middle East and Africa RSV Diagnostic Products Market, By End User, 2020-2028 (USD Billion)
95 Middle East and Africa RSV Diagnostic Products Market, By Country, 2020-2028 (USD Billion)
96 Saudi Arabia RSV Diagnostic Products Market, By Method, 2020-2028 (USD Billion)
97 Saudi Arabia RSV Diagnostic Products Market, By Product Type, 2020-2028 (USD Billion)
98 Saudi Arabia RSV Diagnostic Products Market, By End User, 2020-2028 (USD Billion)
99 UAE RSV Diagnostic Products Market, By Method, 2020-2028 (USD Billion)
100 UAE RSV Diagnostic Products Market, By Product Type, 2020-2028 (USD Billion)
101 UAE RSV Diagnostic Products Market, By End User, 2020-2028 (USD Billion)
102 South Africa RSV Diagnostic Products Market, By Method, 2020-2028 (USD Billion)
103 South Africa RSV Diagnostic Products Market, By Product Type, 2020-2028 (USD Billion)
104 South Africa RSV Diagnostic Products Market, By End User, 2020-2028 (USD Billion)
105 Israel RSV Diagnostic Products Market, By Method, 2020-2028 (USD Billion)
106 Israel RSV Diagnostic Products Market, By Product Type, 2020-2028 (USD Billion)
107 Israel RSV Diagnostic Products Market, By End User, 2020-2028 (USD Billion)
108 Rest of Middle East and Africa RSV Diagnostic Products Market, By Method, 2020-2028 (USD Billion)
109 Rest of Middle East and Africa RSV Diagnostic Products Market, By Product Type, 2020-2028 (USD Billion)
110 Rest of Middle East and Africa RSV Diagnostic Products Market, By End User, 2020-2028 (USD Billion)
111 Central and South America RSV Diagnostic Products Market, By Method, 2020-2028 (USD Billion)
112 Central and South America RSV Diagnostic Products Market, By Product Type, 2020-2028 (USD Billion)
113 Central and South America RSV Diagnostic Products Market, By End User, 2020-2028 (USD Billion)
114 Central and South America RSV Diagnostic Products Market, By Country, 2020-2028 (USD Billion)
115 Brazil RSV Diagnostic Products Market, By Method, 2020-2028 (USD Billion)
116 Brazil RSV Diagnostic Products Market, By Product Type, 2020-2028 (USD Billion)
117 Brazil RSV Diagnostic Products Market, By End User, 2020-2028 (USD Billion)
118 Argentina RSV Diagnostic Products Market, By Method, 2020-2028 (USD Billion)
119 Argentina RSV Diagnostic Products Market, By Product Type, 2020-2028 (USD Billion)
120 Argentina RSV Diagnostic Products Market, By End User, 2020-2028 (USD Billion)
121 Chile RSV Diagnostic Products Market, By Method, 2020-2028 (USD Billion)
122 Chile RSV Diagnostic Products Market, By Product Type, 2020-2028 (USD Billion)
123 Chile RSV Diagnostic Products Market, By End User, 2020-2028 (USD Billion)
124 Rest of Central and South America RSV Diagnostic Products Market, By Method, 2020-2028 (USD Billion)
125 Rest of Central and South America RSV Diagnostic Products Market, By Product Type, 2020-2028 (USD Billion)
126 Rest of Central and South America RSV Diagnostic Products Market, By End User, 2020-2028 (USD Billion)
127 BIOMERIUX: Products & Services Offering
128 BD: Products & Services Offering
129 F. Hoffman La. Roche Ltd.: Products & Services Offering
130 Danaher: Products & Services Offering
131 Thermo Fisher Scientific Inc.: Products & Services Offering
132 LUMINEX CORP.: Products & Services Offering
133 BioCartis : Products & Services Offering
134 Hologic Inc.: Products & Services Offering
135 Beckman Coulter Inc.: Products & Services Offering
136 Bio-Rad Laboratories Inc.: Products & Services Offering
137 Other Companies: Products & Services Offering
LIST OF FIGURES
1 Global RSV Diagnostic Products Market Overview
2 Global RSV Diagnostic Products Market Value From 2020-2028 (USD Billion)
3 Global RSV Diagnostic Products Market Share, By Method (2022)
4 Global RSV Diagnostic Products Market Share, By Product Type (2022)
5 Global RSV Diagnostic Products Market Share, By End User (2022)
6 Global RSV Diagnostic Products Market, By Region (Asia Pacific Market)
7 Technological Trends In Global RSV Diagnostic Products Market
8 Four Quadrant Competitor Positioning Matrix
9 Impact Of Macro & Micro Indicators On The Market
10 Impact Of Key Drivers On The Global RSV Diagnostic Products Market
11 Impact Of Challenges On The Global RSV Diagnostic Products Market
12 Porter’s Five Forces Analysis
13 Global RSV Diagnostic Products Market: By Method Scope Key Takeaways
14 Global RSV Diagnostic Products Market, By Method Segment: Revenue Growth Analysis
15 Molecular Diagnostics Market, By Region, 2020-2028 (USD Billion)
16 Rapid Antigen Detection Test Market, By Region, 2020-2028 (USD Billion)
17 Other Methods Market, By Region, 2020-2028 (USD Billion)
18 Global RSV Diagnostic Products Market: By Product Type Scope Key Takeaways
19 Global RSV Diagnostic Products Market, By Product Type Segment: Revenue Growth Analysis
20 Kits and Assays Market, By Region, 2020-2028 (USD Billion)
21 Instruments Market, By Region, 2020-2028 (USD Billion)
22 Other Products Market, By Region, 2020-2028 (USD Billion)
23 Global RSV Diagnostic Products Market: By End User Scope Key Takeaways
24 Global RSV Diagnostic Products Market, By End User Segment: Revenue Growth Analysis
25 Hospitals & Clinics Market, By Region, 2020-2028 (USD Billion)
26 Clinical Laboratories Market, By Region, 2020-2028 (USD Billion)
27 Other End Users Market, By Region, 2020-2028 (USD Billion)
28 Regional Segment: Revenue Growth Analysis
29 Global RSV Diagnostic Products Market: Regional Analysis
30 North America RSV Diagnostic Products Market Overview
31 North America RSV Diagnostic Products Market, By Method
32 North America RSV Diagnostic Products Market, By Product Type
33 North America RSV Diagnostic Products Market, By End User
34 North America RSV Diagnostic Products Market, By Country
35 U.S. RSV Diagnostic Products Market, By Method
36 U.S. RSV Diagnostic Products Market, By Product Type
37 U.S. RSV Diagnostic Products Market, By End User
38 Canada RSV Diagnostic Products Market, By Method
39 Canada RSV Diagnostic Products Market, By Product Type
40 Canada RSV Diagnostic Products Market, By End User
41 Mexico RSV Diagnostic Products Market, By Method
42 Mexico RSV Diagnostic Products Market, By Product Type
43 Mexico RSV Diagnostic Products Market, By End User
44 Four Quadrant Positioning Matrix
45 Company Market Share Analysis
46 BioMeriux: Company Snapshot
47 BioMeriux: SWOT Analysis
48 BioMeriux: Geographic Presence
49 BD: Company Snapshot
50 BD: SWOT Analysis
51 BD: Geographic Presence
52 F. Hoffman La. Roche Ltd.: Company Snapshot
53 F. Hoffman La. Roche Ltd.: SWOT Analysis
54 F. Hoffman La. Roche Ltd.: Geographic Presence
55 Danaher: Company Snapshot
56 Danaher: Swot Analysis
57 Danaher: Geographic Presence
58 Thermo Fisher Scientific Inc.: Company Snapshot
59 Thermo Fisher Scientific Inc.: SWOT Analysis
60 Thermo Fisher Scientific Inc.: Geographic Presence
61 Luminex Corp.: Company Snapshot
62 Luminex Corp.: SWOT Analysis
63 Luminex Corp.: Geographic Presence
64 BioCartis : Company Snapshot
65 BioCartis : SWOT Analysis
66 BioCartis : Geographic Presence
67 Hologic Inc.: Company Snapshot
68 Hologic Inc.: SWOT Analysis
69 Hologic Inc.: Geographic Presence
70 Beckman Coulter Inc.: Company Snapshot
71 Beckman Coulter Inc.: SWOT Analysis
72 Beckman Coulter Inc.: Geographic Presence
73 Bio-Rad Laboratories Inc.: Company Snapshot
74 Bio-Rad Laboratories Inc.: SWOT Analysis
75 Bio-Rad Laboratories Inc.: Geographic Presence
76 Other Companies: Company Snapshot
77 Other Companies: SWOT Analysis
78 Other Companies: Geographic Presence
The Global RSV Diagnostic Products Market has been studied from the year 2019 till 2028. However, the CAGR provided in the report is from the year 2023 to 2028. The research methodology involved three stages: Desk research, Primary research, and Analysis & Output from the entire research process.
The desk research involved a robust background study which meant referring to paid and unpaid databases to understand the market dynamics; mapping contracts from press releases; identifying the key players in the market, studying their product portfolio, competition level, annual reports/SEC filings & investor presentations; and learning the demand and supply-side analysis for the RSV Diagnostic Products Market.
The primary research activity included telephonic conversations with more than 50 tier 1 industry consultants, distributors, and end-use product manufacturers.
Finally, based on the above thorough research process, an in-depth analysis was carried out considering the following aspects: market attractiveness, current & future market trends, market share analysis, SWOT analysis of the company and customer analytics.
Frequently Asked Questions
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
Or view our licence options:
Tailor made solutions just for you
80% of our clients seek made-to-order reports. How do you want us to tailor yours?
OUR CLIENTS
